Helium-3 of the airway tree, locate unventilated defects, measure the alveolar oxygen partial pressure, and measure the ventilation/perfusion ratio. This technique may be critical for the diagnosis and treatment management of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), emphysema, cystic fibrosis, and asthma. Production, sales and distribution of helium-3 in the United States are managed by the US Department of Energy (DOE) Isotope Program. Virtually all helium-3 used in industry today is produced from the radioactive decay of tritium. Tritium is a radioactive isotope of hydrogen and is typically produced by bombarding lithium-6 with neutrons in a nuclear
Tritium MeV. In comparison, the fusion of deuterium with tritium releases about 17.6 MeV of energy. For applications in proposed fusion energy reactors, such as ITER, pebbles consisting of lithium bearing ceramics including LiTiO and LiSiO, are being developed for tritium breeding within a helium cooled pebble bed (HCPB), also known as a breeder blanket. High-energy neutrons can also produce tritium from lithium-7 in an endothermic (net heat consuming) reaction, consuming 2.466 MeV. This was discovered when the 1954 Castle Bravo nuclear test produced an unexpectedly high yield. High-energy neutrons irradiating boron-10 will also occasionally produce tritium: A more common result